Written and maintained by CASRAI Editorial Board
Published
On this page
The GRACE Risk Score—derived from the multinational Global Registry of Acute Coronary Events (GRACE) (Granger et al., Archives of Internal Medicine 2003; Fox et al., BMJ 2006)—is a prospectively validated multivariable prognostic model used to estimate the probability of all-cause mortality and myocardial infarction (MI) in patients presenting with an Acute Coronary Syndrome (ACS). Unlike single-cohort trial models restricted to either unstable angina or ST-elevation events, the GRACE score was derived and externally validated across an unselected real-world registry of more than 100,000 patients spanning the complete ACS spectrum: ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA).
What Is the GRACE Risk Score? The 8 Core Clinical Variables
A clinical GRACE score calculator combines four continuous physiological/laboratory parameters, one four-level hemodynamic severity classification, and three binary admission findings recorded at initial hospital presentation:
| Variable # | Clinical Parameter | Measurement Scale & Prognostic Weighting | GRACE 2.0 Mini-Model Substitution |
|---|---|---|---|
| 1 | Age | Continuous (years); mortality risk increases exponentially above age 60. | Required directly |
| 2 | Heart Rate / Pulse | Continuous (beats per minute at admission); sinus tachycardia reflects sympathetic activation or LV dysfunction. | Required directly |
| 3 | Systolic Blood Pressure (SBP) | Continuous (mmHg at admission); inverse relationship—hypotension (e.g., SBP < 100 mmHg) carries the highest risk points. | Required directly |
| 4 | Serum Creatinine | Continuous (mg/dL or µmol/L); reflects baseline renal function and cardiorenal hypoperfusion. | Can substitute binary history of renal insufficiency before lab return |
| 5 | Killip Classification | Ordinal Classes I–IV (Killip classification of acute heart failure: Class I no rales, Class II rales/S3, Class III pulmonary edema, Class IV cardiogenic shock). | Can substitute diuretic usage if formal Killip class is undocumented |
| 6 | Cardiac Arrest at Admission | Binary (Yes / No); resuscitation from ventricular fibrillation or pulseless arrest at presentation. | Required directly |
| 7 | ST-Segment Deviation on Index ECG | Binary (Yes / No); transient or persistent ST elevation or ST depression ≥ 0.5–1.0 mm. | Required directly |
| 8 | Elevated Cardiac Biomarkers / Troponin | Binary (Yes / No); high-sensitivity cardiac troponin T/I (hs-cTn) or CK-MB above the 99th percentile upper reference limit. | Required directly |
GRACE 1.0 Point Nomogram vs. GRACE 2.0 Non-Linear Algorithm
The original GRACE 1.0 model sums integer point weights assigned to binned intervals of the 8 variables to predict in-hospital mortality and admission-to-6-month mortality or MI. The updated GRACE 2.0 algorithm (Fox et al., European Heart Journal 2014, validated in over 32,000 patients from the FAST-MI and GRACE cohorts) evaluates continuous variables using non-linear mathematical functions directly without loss of precision from point binning, extending validated risk predictions to 1-year and 3-year mortality and permitting immediate pre-hospital or emergency department scoring via the renal insufficiency and diuretic substitutions before serum creatinine labs return.
GRACE Risk Stratification Cutoffs and Invasive Coronary Angiography Timing
In both the European Society of Cardiology (ESC) Guidelines for the Management of Acute Coronary Syndromes and the AHA/ACC Guidelines for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes (NSTE-ACS), the GRACE score is a cornerstone of cardiac risk stratification used to determine the urgency of diagnostic coronary angiography and revascularization:
| Risk Category (NSTE-ACS In-Hospital) | GRACE 1.0 Point Range | Estimated In-Hospital Mortality | Guideline-Recommended Management Strategy |
|---|---|---|---|
| Low Risk | ≤ 108 points | < 1.0% | Selective invasive strategy or non-invasive anatomical/functional ischemia testing (e.g., CCTA or stress imaging) prior to discharge. |
| Intermediate Risk | 109 – 140 points | 1.0% – 3.0% | Invasive coronary angiography during index hospitalization (typically within 24–72 hours) depending on clinical comorbidities and dynamic symptoms. |
| High Risk | > 140 points | > 3.0% | Early invasive strategy within 24 hours of hospital admission, alongside intensive care or telemetry monitoring and dual antiplatelet therapy. |
Note on Admission-to-6-Month Post-Discharge Cutoffs: When using the GRACE 6-month post-discharge mortality nomogram in NSTE-ACS, the point thresholds shift to Low Risk (≤ 88 points, < 3% mortality), Intermediate Risk (89–118 points, 3%–8% mortality), and High Risk (> 118 points, > 8% mortality).
How Is the GRACE Risk Score Used in Clinical Research and Healthcare?
Beyond bedside catheterization triage, the GRACE score serves three critical functions in cardiovascular medicine and clinical trials:
- GRACE vs. TIMI vs. HEART Score Selection: Clinicians select cardiac scores based on the clinical setting and diagnostic question. The HEART Score is designed for undifferentiated Emergency Department chest pain triage (identifying low-risk patients safe for early ED discharge). Once a diagnosis of UA/NSTEMI is established, both the TIMI Score (a simple 0–7 point bedside additive checklist predicting 14-day all-cause mortality, new/recurrent MI, or severe recurrent ischemia requiring urgent revascularization) and the GRACE Score stratify prognosis—with comparative validation studies consistently demonstrating superior discriminative accuracy (higher C-statistic / AUC, typically
0.81–0.85) for GRACE in predicting short- and long-term mortality because it incorporates hemodynamic vital signs (SBP, HR, Killip class) and renal function (creatinine). - EHR Clinical Decision Support (CDS) Integration: Hospitals embed automated GRACE 2.0 calculators inside EHR admission workflows as non-interruptive clinical decision support tools, automatically pulling age, triage vitals, serum creatinine, and troponin results via HL7 FHIR to flag patients with a GRACE score > 140 for expedited cardiology consultation.
- Clinical Trial Enrichment and Case-Mix Risk Adjustment: Cardiovascular clinical trials (such as the TIMACS and VERDICT trials evaluating early vs. delayed invasive angiography in NSTE-ACS) use a baseline GRACE score > 140 as a prespecified subgroup stratification criterion, while national myocardial infarction registries (such as UK MINAP and SWEDEHEART) use baseline GRACE distributions to risk-adjust hospital mortality benchmarking.
Frequently Asked Questions
What is the GRACE risk score?
The GRACE (Global Registry of Acute Coronary Events) Risk Score is an 8-variable clinical prediction model that calculates a patient’s probability of in-hospital and post-discharge (6-month, 1-year, and 3-year) death or myocardial infarction following an acute coronary syndrome (STEMI, NSTEMI, or unstable angina). It incorporates age, heart rate, systolic blood pressure, serum creatinine, Killip class, cardiac arrest at admission, ST-segment deviation, and elevated cardiac biomarkers.
How is the GRACE risk score used in clinical research and healthcare?
In hospital cardiology, the GRACE risk score guides the timing of invasive coronary angiography in NSTE-ACS: under ESC and AHA/ACC guidelines, a GRACE score greater than 140 identifies high-risk patients who benefit from an early invasive catheterization strategy within 24 hours of admission. In clinical research, it is used to stratify high-risk subgroups in randomized ACS trials and to risk-adjust hospital mortality outcomes in national cardiac registries.







